NEWS
Alborzinia et al., 2022
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/07/Alborizina-et-al22.png
628
683
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-04-28 17:58:502023-09-21 11:28:32Nat cancer: MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/01/CatStartup-1.jpg
338
432
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-01-30 14:14:032024-03-21 12:58:59Start-up funding: Characterization of gene regulatory networks and ferroptosis sensitivity of drug-tolerant melanoma
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/01/CatStartup-1.jpg
338
432
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-01-30 09:27:362024-03-21 13:01:00Start-up funding: Using APEX2 as a chemogenetic tool to study ferroptosis in vivo

